导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.67% | 799/1050 |
| 近一周 | -2.88% | 767/1104 |
| 近一月 | -7.11% | 832/1102 |
| 近一季 | -6.25% | 479/1092 |
| 近半年 | -8.55% | 720/1070 |
| 近一年 | -6.40% | 677/1018 |
| 近两年 | 50.41% | 504/926 |
| 近三年 | 33.19% | 366/834 |
| 成立以来 | 55.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.16% 978/1070 |
17.37% 418/1101 |
- - |
- - |
| 2025 | 42.85% 282/1065 |
6.68% 305/1014 |
9.47% 121/1038 |
24.09% 475/1050 |
-1.42% 525/1065 |
| 2024 | 16.59% 137/1011 |
1.44% 237/960 |
6.40% 69/983 |
18.15% 100/991 |
-8.56% 846/1011 |
| 2023 | -22.06% 724/952 |
-2.08% 717/880 |
-9.69% 758/895 |
-3.13% 209/915 |
-9.01% 814/952 |
| 2022 | -10.63% 91/867 |
-11.19% 132/773 |
5.63% 484/806 |
-14.61% 546/845 |
11.57% 57/867 |
| 2021 | 8.49% 266/740 |
14.56% 3/580 |
-2.91% 571/659 |
0.87% 206/704 |
-3.30% 550/740 |
| 2020 | - - |
- - |
- - |
8.52% 288/517 |
11.37% 315/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实基础产业优选股票C VS. 东吴新产业精选股票A(580008) |